Assessment of the effect of Metformin on the plasma LDL-C levels at T2DM patients

Authors

  • roula yosef Tishreen University
  • Rana Makhous Tishreen University
  • Younes Kabalan Damascus University

Abstract

Type 2 diabetes is a chronic and progressive metabolic disease, associated with a significantly high risk of early atherosclerotic coronary heart disease. It is believed that the basic relation between diabetes and heart problems is due to Lipid disturbances (diabetic dyslipidemia). There are many evidences about the effect of metformin on blood lipids in addition to being a hypoglycemic agent. This study aimed to evaluate the effect of metformin on LDL-Cholesterol in patients with T2DM. The Multicenter Comparative (Before- After) Study was conducted at Al-Mouwasat and Al-Assad University Hospitals in addition to Al-Zahira Comprehensive Clinics Center in Damascus-Syria. The study included 56 patients (28 newly diagnosed with T2DM and 28 with pre-diabetes) who received metformin treatment. LDL-C values were measured before and three months after taking treatment. At the end of the study, there was a statistically significant decrease in LDL-C levels after treatment with metformin, P-value = 0.0001, and the percentage of decrease was estimated at 9.61%, but this effect wasn't dose-dependent. We noticed that metformin's ability to lower plasma LDL-C levels was not directly related to its ability to lower blood's glucose. Our study showed that metformin has a good positive effect on a risk indicator of atherosclerotic heart disease, which is LDL-C in patients with T2DM.

Downloads

Published

2023-09-18

How to Cite

1.
يوسف ر, رنا ماخوس, يونس قبلان. Assessment of the effect of Metformin on the plasma LDL-C levels at T2DM patients. Tuj-hlth [Internet]. 2023Sep.18 [cited 2025Jan.21];45(4):423-32. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/15239

Issue

Vol. 45 No. 4 (2023): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.